Skip to main content
Clinical Trials/CTRI/2021/04/032666
CTRI/2021/04/032666
Completed
未知

Comparative evaluation of the anaesthetic efficacy of supplemental intraligamentary injection of lignocaine, bupivacaine and tramadol hydrochloride for reduction of intraoperative endodontic pain of symptomatic irreversible pulpitis in mandibular molars-A Randomised clinical study

DrManan Shroff0 sites99 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K00-K14- Diseases of oral cavity and salivary glands
Sponsor
DrManan Shroff
Enrollment
99
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 31, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DrManan Shroff

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with symptomatic irreversible pulpitis with hot tooth confirmed by pulp sensitivity, clinical and radiographic examination.Patient should have actively experiencing moderate to severe pain on VAS scale of 5 or more.Patients with no history of previous initiation of root canal therapy.

Exclusion Criteria

  • Patients with known hypersensitivity to lidocaine,bupivacaine or tramadol. pregnant or lactating mothers. patients with fracture or visibly cracked teeth.

Outcomes

Primary Outcomes

Not specified

Similar Trials